Diabetes drug trial offers hope for teens with fatty livers
Disease control
Recruiting now
This study is testing if a medication called empagliflozin, currently used for diabetes, can safely reduce fat in the liver of obese teenagers with non-alcoholic fatty liver disease (NAFLD). Forty adolescents will take the drug or a placebo for 26 weeks while also receiving lifes…
Phase: PHASE2 • Sponsor: Justin Ryder • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC